The clinical-stage biotech company that develops stem cell treatments posted revenue of $2.6 million in the period, which also did not meet Street ...
News
- Fate Therapeutics: 1Q Earnings Snapshot
- Cara: 1Q Earnings Snapshot
The biotechnology company posted revenue of $4.4 million in the period, also missing Street forecasts. Four analysts surveyed by Zacks expected ...
- Enanta Pharmaceuticals: Fiscal 2Q Earnings Snapshot
The biotechnology company posted revenue of $39.6 million in the period, which fell short of Street forecasts. Four analysts surveyed by Zacks ...
- Senate plans to freeze UMass tuition in budget draws rebuke
... a disease changing therapy that works for them," said Robert Coughlin, president and chief executive of the Massachusetts Biotechnology Council, ...
- Science Says: Why biodiversity matters to you
... scientific technique called polymerase chain reaction (PCR) that is used for medical, genetic and forensic tests and much of modern biotechnology.